Biological drugs such as gene therapies and messenger RNA (mRNA) vaccines frequently rely on lipid nanoparticles (LNPs) coated in a layer of polyethylene glycol (PEG) to deliver medications to the ...
The change in proteinuria was significantly greater with pegcetacoplan than placebo, representing a 68.1% relative reduction vs placebo. HealthDay News — Among patients with C3 glomerulopathy or ...
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient in lipid nanoparticles (LNPs) that ...
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials. Polyethylene glycol, commonly known as PEG ...
A new material could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger unwanted immune responses in some people. (Nanowerk ...
WEDNESDAY, Dec. 10, 2025 (HealthDay News) -- Among patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis (MPGN), pegcetacoplan, a C3 and C3b inhibitor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results